US Army units will soon begin receiving a chemical detection system designed to simplify and enhance neurotoxin detection, with plans to expand the technology’s use cases in the coming years.

The Contamination Indicator/Decontamination Assurance System (CIDAS) was developed with initial funding from the Army Research Office (ARO), part of the US Army Combat Capabilities Development Command’s Army Research Laboratory (ARL). CIDAS is the FLIR Agentase C2 Disclosure Spray, and the system initially stemmed from funded efforts between ARL and researchers at the University of Pittsburgh, with the latter founding a company – Agentase, LLC – in 1999 to further pursue the work. This company was acquired by FLIR Systems in 2010.

US Army units will soon begin receiving a chemical detection system designed to simplify and enhance neurotoxin detection, with plans to expand the technology’s use cases in the coming years.

The Contamination Indicator/Decontamination Assurance System (CIDAS) was developed with initial funding from the Army Research Office (ARO), part of the US Army Combat Capabilities Development Command’s Army Research Laboratory (ARL). CIDAS is the FLIR Agentase C2 Disclosure Spray, and the system initially stemmed from funded efforts between ARL and researchers at the University of Pittsburgh, with the latter founding a company – Agentase, LLC – in 1999 to further pursue the work. This company was acquired by FLIR Systems in 2010.

US Army units will soon begin receiving a chemical detection system designed to simplify and enhance neurotoxin detection, with plans to expand the technology’s use cases in the coming years.

The Contamination Indicator/Decontamination Assurance System (CIDAS) was developed with initial funding from the Army Research Office (ARO), part of the US Army Combat Capabilities Development Command’s Army Research Laboratory (ARL). CIDAS is the FLIR Agentase C2 Disclosure Spray, and the system initially stemmed from funded efforts between ARL and researchers at the University of Pittsburgh, with the latter founding a company – Agentase, LLC – in 1999 to further pursue the work. This company was acquired by FLIR Systems in 2010.

US Army units will soon begin receiving a chemical detection system designed to simplify and enhance neurotoxin detection, with plans to expand the technology’s use cases in the coming years.

The Contamination Indicator/Decontamination Assurance System (CIDAS) was developed with initial funding from the Army Research Office (ARO), part of the US Army Combat Capabilities Development Command’s Army Research Laboratory (ARL). CIDAS is the FLIR Agentase C2 Disclosure Spray, and the system initially stemmed from funded efforts between ARL and researchers at the University of Pittsburgh, with the latter founding a company – Agentase, LLC – in 1999 to further pursue the work. This company was acquired by FLIR Systems in 2010.

US Army units will soon begin receiving a chemical detection system designed to simplify and enhance neurotoxin detection, with plans to expand the technology’s use cases in the coming years.

The Contamination Indicator/Decontamination Assurance System (CIDAS) was developed with initial funding from the Army Research Office (ARO), part of the US Army Combat Capabilities Development Command’s Army Research Laboratory (ARL). CIDAS is the FLIR Agentase C2 Disclosure Spray, and the system initially stemmed from funded efforts between ARL and researchers at the University of Pittsburgh, with the latter founding a company – Agentase, LLC – in 1999 to further pursue the work. This company was acquired by FLIR Systems in 2010.

US Army units will soon begin receiving a chemical detection system designed to simplify and enhance neurotoxin detection, with plans to expand the technology’s use cases in the coming years.

The Contamination Indicator/Decontamination Assurance System (CIDAS) was developed with initial funding from the Army Research Office (ARO), part of the US Army Combat Capabilities Development Command’s Army Research Laboratory (ARL). CIDAS is the FLIR Agentase C2 Disclosure Spray, and the system initially stemmed from funded efforts between ARL and researchers at the University of Pittsburgh, with the latter founding a company – Agentase, LLC – in 1999 to further pursue the work. This company was acquired by FLIR Systems in 2010.